- Folate and B Vitamins Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
- Lipoproteins and Cardiovascular Health
- Diabetes Management and Research
- Diabetes and associated disorders
- Pituitary Gland Disorders and Treatments
- Acute Myocardial Infarction Research
- Animal Virus Infections Studies
- Health and Lifestyle Studies
- Adipokines, Inflammation, and Metabolic Diseases
- Healthcare during COVID-19 Pandemic
- Cardiovascular Disease and Adiposity
- Thyroid Disorders and Treatments
- Climate Change and Health Impacts
- Histone Deacetylase Inhibitors Research
- Growth Hormone and Insulin-like Growth Factors
- Peripheral Artery Disease Management
- Renal Diseases and Glomerulopathies
- Healthcare cost, quality, practices
- Viral Infections and Immunology Research
- Chronic Kidney Disease and Diabetes
- Cerebrovascular and Carotid Artery Diseases
- Moyamoya disease diagnosis and treatment
- GDF15 and Related Biomarkers
Paralab (Portugal)
2025
Centro Hospitalar de Lisboa Ocidental
1994-2023
Hospital de Egas Moniz
2016-2021
Hospital of St. Francis Xavier
2017-2018
Centro De Medicina Veterinária Anjos De Assis
1994
A doença renal crónica representa um problema de saúde pública significativo, afetando cerca 9,8% da população adulta em Portugal. Pese embora este número, o diagnóstico precoce desta nos grupos alto risco é reduzido. Apesar serem apenas dois os parâmetros cruciais para seu – a taxa filtração glomerular estimada (TFGe) e albuminúria Portugal, mais 50% dos doentes estádio 3 - 5 não foram alvo avaliação concomitante TFGe albuminúria. falta implementação destas duas métricas simultâneo, leva à...
Torque teno virus (TTV) was recently identified as a potential biomarker for the degree of immunosuppression, and potentially predictor rejection infection in solid organ transplant patients. We evaluated TTV viral load kidney (KT) patients during first year post-transplant to examine overall kinetics their relationships with deleterious events, including episodes formation de novo donor-specific antibodies (DSAs). In single-center, prospective observational cohort study, 81 KT were...
Introdução: A diabetes mellitus tipo 2 é uma entidade comum, afetando até 13,1% da população portuguesa. Para além das conhecidas complicações micro e macrovasculares, as iatrogenias medicamentosas tornaram-se crescente preocupação contribuindo para observadas alterações recomendações terapêuticas, que cada vez mais privilegiam a segurança em detrimento eficácia. metformina o agente farmacológico de primeira linha na maioria dos doentes com 2, contudo, está descrita associação défice...
Metformin is the cornerstone of pharmacological therapy for type 2 diabetes mellitus (T2DM). It belongs to biguanide class drugs and it improves hepatic insulin resistance enhances GLP-1 peptide YY secretion. Despite being considered safe regarding hypoglycemic risk, renal dysfunction remains main obstacle its use due underlying risk lactic acidosis. In recent past many authors used creatinine values as decisive marker when came choose between agents in DM. Serum equal or above 1.4 1.5 mg/dL...
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Introduction: Healthcare facilities are among the greatest contributors to resource consumption and waste generation. Nephrology is one of most polluting medical areas, mostly due hemodialysis (HD). Incremental (iHD) has gained attention several clinical advantages, by decreasing number sessions while patient still residual kidney function. Beyond these benefits, this regimen might also be both more economical environmentally friendly. The aim study was evaluate potential reduction...
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | 1479-6848 (online)